Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUGAMMADEX ELM 100 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SUGAMMADEX ELM 100 MG/ML SOLUCIÓN INYECTABLE EFG

Approved

STANDARD

SUGAMMADEX ELM 100 MG/ML SOLUCIÓN INYECTABLE EFG

Laboratorios Lorien S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 22, 2024
Approval ID: b68edd85bb17e3ba
Company: Laboratorios Lorien S.L.
Type: Standard

Approval Details

Approval Id: b68edd85bb17e3ba
Drug Cima Aemps Name: SUGAMMADEX ELM 100 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number: 89452
Holder Company Name: Laboratorios Lorien S.L.
Marketing Company Name: Laboratorios Lorien S.L.
Authorization Date: 2024-03-22
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 100 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Laboratorios Lorien S.L.

Active Ingredients

SUGAMMADEX

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 22, 2024

Approval ID

b68edd85bb17e3ba

Type

Standard

Back to CIMA-AEMPS Approvals